Does GILTERITINIB Cause Neuropathy peripheral? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Neuropathy peripheral have been filed in association with GILTERITINIB (Xospata). This represents 0.3% of all adverse event reports for GILTERITINIB.
12
Reports of Neuropathy peripheral with GILTERITINIB
0.3%
of all GILTERITINIB reports
3
Deaths
5
Hospitalizations
How Dangerous Is Neuropathy peripheral From GILTERITINIB?
Of the 12 reports, 3 (25.0%) resulted in death, 5 (41.7%) required hospitalization.
Is Neuropathy peripheral Listed in the Official Label?
Yes, Neuropathy peripheral is listed as a known adverse reaction in the official FDA drug label for GILTERITINIB.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which GILTERITINIB Alternatives Have Lower Neuropathy peripheral Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB